Newton C R, MacCallum L J, McPheat W, Carr H, Foster H R, Abbott W M, Needham M, Dinsmore A, Copley C G
ZENECA Pharmaceuticals, Macclesfield, Cheshire, United Kingdom.
Protein Expr Purif. 1994 Oct;5(5):449-57. doi: 10.1006/prep.1994.1064.
We have cloned, expressed, and purified the extracellular domains of types I and II human tumor necrosis factor receptors. Both proteins were expressed in and secreted by murine erythroleukemia cells under the control of the human beta-globin promoter placed down-stream from the human globin locus control region. Secretion of both proteins was directed by the respective tumor necrosis factor receptor signal sequence. Each tumor necrosis factor receptor extracellular domain was expressed as a chimeric protein, fused to a carboxy terminal flexible peptide linker and an antigenic affinity tag. Secretion of both proteins into the growth medium in a hollow fiber bioreactor was achieved. A monoclonal antibody generated against the affinity tag allowed the purification of both proteins. These were isolated as biologically active products in that they bound human tumor necrosis factor-alpha in a 125I-radioiodinated ligand binding assay. The two proteins also bound tumor necrosis factor-alpha at approximately equimolar ratios as demonstrated by BIAcore sensorgram analysis.
我们已经克隆、表达并纯化了I型和II型人肿瘤坏死因子受体的胞外结构域。这两种蛋白质在人β-珠蛋白启动子的控制下,在人珠蛋白基因座控制区下游,由鼠红白血病细胞表达并分泌。两种蛋白质的分泌由各自的肿瘤坏死因子受体信号序列引导。每个肿瘤坏死因子受体胞外结构域都表达为嵌合蛋白,与羧基末端柔性肽接头和抗原亲和标签融合。两种蛋白质均通过中空纤维生物反应器分泌到生长培养基中。针对亲和标签产生的单克隆抗体可用于纯化这两种蛋白质。它们作为生物活性产物被分离出来,因为在125I放射性碘化配体结合试验中它们与人肿瘤坏死因子-α结合。BIAcore传感器图分析表明,这两种蛋白质也以大约等摩尔比结合肿瘤坏死因子-α。